cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet

RxCUI: 2475199
RxNorm name: cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet
Display name: cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet
Full name: cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet
Term type: SY
Status: DailyMed mapping
Updated: 2026-06-04 23:39:01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Vocabria	CABOTEGRAVIR SODIUM	ViiV Healthcare Company	66d450fb-cca4-476c-b0c7-c0730e3e4cf3	2025-04-11	Warnings, Adverse reactions	Exact identifier rxcui: 2475199

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set ID	RxNorm mappings	Terms	SPL version	Label	Effective
66d450fb-cca4-476c-b0c7-c0730e3e4cf3	cabotegravir 30 MG Oral Tablet [PSN] · cabotegravir 30 MG Oral Tablet [SCD] · cabotegravir 30 MG (as cabotegravir sodium 31.62 MG) Oral Tablet [SY]	3	8	These highlights do not include all the information needed to use VOCABRIA safely and effectively. See full prescribing information for VOCABRIA. VOCABRIA (cabotegravir) tablets, for oral use Initial U.S. Approval: 2021	20250411